Linc01271 promotes lipid synthesis and MASLD/MASH progression via miR-149-3p/RAB35 axis

Zhaoqing Yin1,2, Caibin Yue3,4, Zhipeng Li1,2

  • 1Department of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China.

Insights

Long non-coding RNA Linc01271 promotes metabolic associated steatohepatitis (MASH) by increasing lipid synthesis and inflammation. Targeting Linc01271 may offer a new therapeutic strategy for MASH.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Genetics

Background:

  • Metabolic associated steatohepatitis (MASH) is a severe liver condition linked to metabolic dysfunction.
  • The precise molecular drivers of MASH progression are not fully understood.
  • Identifying novel molecular targets is crucial for developing effective MASH therapies.

Purpose of the Study:

  • To investigate the role of long non-coding RNA Linc01271 in the pathogenesis of MASH.
  • To elucidate the molecular mechanisms involving the miR-149-3p/RAB35 axis and PI3K/AKT/mTOR pathway in MASH.
  • To assess Linc01271 as a potential therapeutic target for MASH.

Main Methods:

  • Transcriptome sequencing and RT-qPCR to analyze Linc01271 expression in MASH tissues.
  • In vitro experiments using THLE-2 cells to assess the effects of Linc01271 knockdown or overexpression on lipid metabolism and inflammation.
  • Dual-luciferase reporter assays to confirm interactions between Linc01271 and miR-149-3p.
  • In vivo studies in mice to evaluate the impact of Linc01271 knockdown on MASH progression.

Main Results:

  • Linc01271 was significantly upregulated in MASH tissues, correlating with increased lipid accumulation and inflammation.
  • Linc01271 knockdown in cells reduced lipid synthesis and pro-inflammatory cytokine expression.
  • Linc01271 was confirmed to interact with miR-149-3p, influencing the regulation of RAB35.
  • Linc01271 knockdown in mice ameliorated MASH, reducing liver injury and metabolic dysfunction markers.

Conclusions:

  • Linc01271 promotes MASH by enhancing lipid synthesis and inflammatory responses via the miR-149-3p/RAB35 axis and PI3K/AKT/mTOR pathway.
  • Linc01271 represents a promising therapeutic target for MASLD/MASH.
  • Further investigation is needed to develop Linc01271-targeted therapies for clinical application.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
867
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.0K